GHT

GHT is an acronym that can refer to several topics depending on the domain. In medical contexts, the most common meaning is Growth Hormone Therapy, a treatment that uses growth hormone to address deficiencies and certain growth-related conditions.

Growth Hormone Therapy (GHT) involves the administration of recombinant human growth hormone, typically by subcutaneous injection. In children, GHT is indicated for growth hormone deficiency and various conditions associated with short stature, such as Turner syndrome, Prader-Willi syndrome, idiopathic short stature, and some chronic kidney diseases. In adults, GHT is used to treat growth hormone deficiency and may help improve body composition, physical performance, and quality of life. Dosing is individualized and supervised by endocrinologists. Treatment duration varies, often spanning months to years, with regular monitoring of growth or development, metabolic parameters, and overall response. Common adverse effects include injection-site reactions, edema, joint or muscle pain, headaches, and glucose intolerance; rare but serious risks require ongoing assessment. The safety and efficacy of GHT depend on accurate diagnosis, appropriate dosing, and consistent follow-up.

Outside medicine, the acronym GHT may appear in various contexts as an abbreviation for organizations, projects, or technical terms. There is no single dominant meaning, so the intended sense of GHT is typically inferred from context. Readers seeking a precise definition should consult context-specific sources.